000 01381 a2200421 4500
005 20250513061811.0
264 0 _c19940329
008 199403s 0 0 eng d
022 _a0300-8916
024 7 _a10.1177/030089169307900512
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBarni, S
245 0 0 _aImmunotherapy with low-dose subcutaneous interleukin-2 plus beta-interferon as a second-line therapy for metastatic colorectal carcinoma.
_h[electronic resource]
260 _bTumori
_cOct 1993
300 _a343-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aColorectal Neoplasms
_xtherapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aInjections, Subcutaneous
650 0 4 _aInterferon-beta
_xadministration & dosage
650 0 4 _aInterleukin-2
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
700 1 _aLissoni, P
700 1 _aArdizzola, A
700 1 _aVigoré, L
700 1 _aVezzo, R
700 1 _aRescaldani, R
700 1 _aTancini, G
773 0 _tTumori
_gvol. 79
_gno. 5
_gp. 343-6
856 4 0 _uhttps://doi.org/10.1177/030089169307900512
_zAvailable from publisher's website
999 _c8115403
_d8115403